SEC Form 4 · accession 0001209191-16-096124
Evoke Pharma Inc · EVOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marilyn R. Carlson
Officer — Chief Medical Officer
Period of report
Feb 5, 2016
Accepted (ET)
Feb 5, 2016 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403708
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $8.67 | Feb 5, 2016 | D | 100,000 | D | — | Dec 1, 2023 | Common Stock | 100,000 | 0 | D |
| Stock Option (Right to Buy)F4,F3 | $6.22 | Feb 5, 2016 | D | 45,000 | D | — | Mar 5, 2025 | Common Stock | 45,000 | 0 | D |
| Stock Option (Right to Buy)F5 | $3.04 | Feb 5, 2016 | A | 75,000 | A | — | Dec 1, 2023 | Common Stock | 75,000 | 75,000 | D |
| Stock Option (Right to Buy)F5 | $3.04 | Feb 5, 2016 | A | 33,750 | A | — | Mar 5, 2025 | Common Stock | 33,750 | 33,750 | D |
Explanation of responses
- F125% of the total number of shares of common stock subject to the option vested on December 1, 2014, and the remainder will vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service to the Issuer through each such vesting date.
- F2On February 5, 2016, the Issuer canceled an option granted on December 2, 2013. In exchange for the canceled option, the reporting person received 75,000 options to purchase common stock.
- F3The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2015, subject to the reporting person's continued service to the Issuer through each such vesting date.
- F4On February 5, 2016, the Issuer canceled an option granted on March 6, 2015. In exchange for the canceled option, the reporting person received 33,750 options to purchase common stock.
- F5The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date.